Novonesis AS (Novonesis AS) Debt-to-Equity : 0.55 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS Debt-to-Equity?

Novonesis AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $464 Mil. Novonesis AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $667 Mil. Novonesis AS's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $2,045 Mil. Novonesis AS's debt to equity for the quarter that ended in Dec. 2023 was 0.55.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Novonesis AS's Debt-to-Equity or its related term are showing as below:

NVZMY' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.18 Max: 0.55
Current: 0.55

During the past 13 years, the highest Debt-to-Equity Ratio of Novonesis AS was 0.55. The lowest was 0.04. And the median was 0.18.

NVZMY's Debt-to-Equity is ranked worse than
65.35% of 1397 companies
in the Chemicals industry
Industry Median: 0.35 vs NVZMY: 0.55

Novonesis AS Debt-to-Equity Historical Data

The historical data trend for Novonesis AS's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Debt-to-Equity Chart

Novonesis AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.30

0.05

0.04

0.50

0.55

Novonesis AS Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.50	0.03	0.03	0.03	0.55

Competitive Comparison of Novonesis AS's Debt-to-Equity

For the Specialty Chemicals subindustry, Novonesis AS's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis AS's Debt-to-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Debt-to-Equity falls into.

Novonesis AS Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Novonesis AS's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(464.242	+	667.174)	/	2045.122
	=	0.55

Novonesis AS's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(464.242	+	667.174)	/	2045.122
	=	0.55

Novonesis AS (OTCPK:NVZMY) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Novonesis AS Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis AS (Novonesis AS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

NVZMF:USA NZYM:Mexico NZYMBc:UK 0Q4U:UK NZYM B:Denmark NZM2:Germany

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso • 11-06-2019

Novozymes A/S's Dividend Analysis

By GuruFocus Research • 10-19-2023

Not Just Yogurt Anymore

By PRNewswire • 10-26-2023

Novozymes Named EPA Safer Choice Partner of the Year for Third Year in a Row

By PRNewswire • 10-03-2023